Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin

Diabetes, Obesity and Metabolism

Volumn 1, Issue 2, 1999, Pages 113-120

  Desfaits, A C ^a   Serri, O ^a   Renier, G ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

Adhesion molecule; Advanced glycation end products; Gliclazide; Monocyte adhesion

Indexed keywords

ANTIBODY; ANTIDIABETIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLICLAZIDE; GLYCOSYLATED SERUM ALBUMIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; SERUM ALBUMIN; VASCULAR CELL ADHESION MOLECULE 1;

AORTA; ARTICLE; CELL ADHESION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MONOCYTE; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTIBODIES; AORTA; CELL ADHESION; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GLICLAZIDE; HUMANS; HYPOGLYCEMIC AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; RNA, MESSENGER; SERUM ALBUMIN; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033086242     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.1999.00012.x     Document Type: Article

References (23)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med 1988; 318: 1315-1321.
2. Baynes JW. Role of oxidative stress in the development of complications in diabetes. Diabetes 1991; 40: 405-412.
3. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 1994; 124: 19-30.
4. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992; 15: 1835-1843.
5. Horiuchi S. Advanced glycation end products (AGE)-modified proteins and then potential relevance to atherosclerosis. Trends Cardiovasc Med 1996; 6: 163-168.
6. Springer T. A. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
7. Beekhuizen H, Corsel-van Tilburg AJ, van Furth R. Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J Immunol 1990; 145: 510-518.
8. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thrombosis Haemostasis 1994; 72: 979-984.
9. Fasching P, Veitl M, Rohac M et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4313-4317.
10. Desfaits AC, Serri O, Renier G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment. Diabetes Care 1998; 21: 487-493.
11. Schmidt AM, Hori O, Chen JX et al. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403.
12. Vlassara H, Fuh H, Donnelly T, Cybulsky M. Advanced glycation end products promote adhesion molecules (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1995; 1: 447-456.
13. Desfaits AC, Serri O, Renier G. Gliclazide decreases cell-mediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism 1997; 46: 1150-1156.
14. Pongor S, Ulrich PC, Bencsath FA, Cerami A. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proceed Natl Acad Sci USA 1984; 81: 2684-2688.
15. Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV. Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol 1986; 101: 312-319.
16. Hoover ML, Chapman SW, Cuchens MA. A procedure for the isolation of highly purified populations of B cells, T cells and monocytes from human peripheral and umbilical cord blood. J Immunol Methods 1985; 78: 71-85.
17. Bath PMW, Booth RFC, Hassall DG. Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J Immunol Methods 1989; 118: 59-65.
18. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multiple step paradigm. Cell 1994; 76: 311-314.
19. Scholz D, Devaux B, Hirche A et al. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res 1996; 284: 415-423.
20. Gearing JH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
21. Schmidt AM, Weidman E, Lalla E et al. Advanced glycation end products (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodont Res 1996; 31: 508-551.
22. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Com 1990; 173: 92-99.
23. Scott NA, Jennings PE, Brown J, Belch JJF. Gliclazide: a general free radical scavenger. Eur J Pharmacol 1991; 208: 175-177.